qpid-logo

QPID Health Appoints Jim Dowling as Vice President of Sales

Company Continues to Strengthen Management Team with Experienced Industry Veteran

Boston – September 25, 2014 – QPID Health, a leader in clinical intelligence software, today announced that Jim Dowling has joined the Company as vice president of sales. Mr. Dowling brings a wealth of experience in healthcare information technology sales and business management and will apply this background to assist QPID Health in its rapid expansion.  Mr. Dowling will be based out of the Company’s headquarters in Boston.

Prior to joining QPID Health, Mr. Dowling served as the executive vice president of enterprise, self-service solutions at QuadraMed Corporation, where he played a key role in the sale of the company. Prior to QuadraMed, Mr. Dowling worked at NCR Healthcare, serving as general manager and vice president of sales. He handled operations for the company’s entire product suite. Additionally, Mr. Dowling has held a variety of senior sales and management positions at GE Healthcare IT/IDX Systems, including general manager of the imaging solutions division. Mr. Dowling holds a Bachelor of Science in Marketing from the New York Institute of Technology.

QPID addresses the data overload and lack of usability of EHRs, which make doctors, nurses and other clinicians less productive and can obscure critical patient health factors. QPID automatically extracts the essential patient narrative from structured and unstructured data scattered throughout the patient record. Pertinent patient data is packaged and delivered directly to clinicians, ensuring that decisions are made with the best available information. QPID Health raised $12.3m in Series B funding in May to meet the market demand for its solutions. QPID currently supports over 6,000 active clinical users, up from 4,000 at the end of 2013, its first year of commercial operation.

“At a time when the interest in our solutions is gaining momentum, Jim understands the pain that clinicians are facing just trying to do their jobs and believes QPID will greatly assist in this effort,” said Mike Doyle, QPID Health chief executive officer. “Hospitals are striving for ways to better incorporate their electronic health records into their workflow and are turning to our solutions to facilitate the transformation. With Jim on our team, our company is well positioned to handle the expanding market and to serve our customers with excellence.”

“I’m honored to be joining QPID as the Vice President of Sales,” says Mr. Dowling. “I’m pleased to support our customers through initial technology investments in enterprise EHRs, to a clinical and revenue cycle ROI through the incorporation of QPID’s technology. There is a definite and growing market need for the clinical intelligence that QPID provides. Hospitals and the government have already done the heavy lifting—so to speak—by moving their records from paper to electronic format. I am thrilled to help hospitals take the next step in enabling clinicians to work more efficiently and improve both the health of patients and their bottom line.”

About QPID Health

QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital (MGH) and usage spread virally throughout the Partners HealthCare system hospitals and affiliates including Brigham & Women’s Hospital, Dana-Farber Cancer Institute, Faulkner, Newton-Wellesley Hospital, and North Shore Hospital as well as MGH. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Investors include Matrix Partners, Cardinal Partners, New Leaf Venture Partners, Massachusetts General Physicians Organization and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information.

Media Contact:

Ceara O’Sullivan
NextStep Communications
ceara@nextstepcomms.com
(315) 567-2528

qpid-logo

QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego

The Company’s Growth Necessitates Additional Space and Staff to Facilitate Product Development and Service Customers Nationwide

Boston – September 16, 2014 – QPID Health, a leader in clinical intelligence software, today announced a move to new headquarters in Boston and their first West Coast location in San Diego.  The new headquarters at 175 Federal Street in Boston will house product development, engineering, operations and marketing teams. QPID Health’s new Southern California office will be located at 1000 Aviara Parkway in Carlsbad.  The expansion was needed in order to meet the demands of customers nationwide. Both new locations will be operational at the end of October.

The QPID software platform enables healthcare providers to get the most from their investment in electronic health records (EHRs) by delivering relevant patient information where and when it is needed. EHRs are difficult to use and waste valuable clinician time because of the high volume of data they contain and because they are not organized the way clinicians think. QPID solves that problem.

QPID Health formally launched in late 2012. Since raising $12.3M in venture funding as part of the Company’s Series B earlier this year, the Company has invested in product development and services to further the core mission of ‘Improving Healthcare’. Moving to new space is imperative to support the Company’s growth.

“Our move to a larger Boston headquarters, opening of the San Diego facility, and our willingness to embrace remote employee arrangements underscore our commitment to hiring the best available people, no matter where they are located,” explained Mike Doyle, President & CEO of QPID Health. “I’m grateful for the passion of my team and look forward to our move, as it affords us the ability to further develop our technology and work toward improved clinical care.”

In 2013, QPID Health’s first year of commercial operation, 4,000 active users generated nearly 3 million clinical encounters with QPID’s platform at Partners HealthCare hospitals including Massachusetts General Hospital and Brigham & Women’s Hospital. Today, over 6,000 active users are benefiting from QPID solutions, both within and outside of the Partners network.

About QPID Health

QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital (MGH) and usage spread virally throughout the Partners HealthCare system hospitals and affiliates including Brigham & Women’s Hospital, Dana-Farber Cancer Institute, Faulkner, Newton-Wellesley Hospital, and North Shore Hospital as well as MGH. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Investors include Matrix Partners, Cardinal Partners, New Leaf Venture Partners, Massachusetts General Physicians Organization and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information.

Media Contact:

Ceara O’Sullivan
NextStep Communications
ceara@nextstepcomms.com
(315) 567-2528

CEO Mike Doyle on panel: “Data Driven Decision Making in Healthcare”

QPID Health’s Mike Doyle has been invited to join the ChicagoConversations panel on Data Driven Decision Making in Healthcare. A Chicago Booth School of Business alumnus, Mike’s background in optimizing healthcare in the age of EHRs will enrich the conversation. You can learn more and register here for the event to be held at 6:30 pm in San Francisco.

The discussion will be focused on the challenges of achieving the promised benefits of digital health:

The implementation of electronic health records (EHR), advent of mobile health, and increasingly sophisticated data analytics are rapidly changing the health care industry, and the industry is poised to bring the advancements necessary to create a leaner, savvier, more efficient health care system. Benefits include: evidence-based, cost-effective treatments, remote monitoring and telemedicine, increased awareness of patient risks and preventative care implementation, and improved fraud and abuse detection.

Yet, before those benefits can be reaped there are a number of challenges to explore. How can data be structured consistently and converted into real-time analytics that are both accessible and secure? What are the barriers to interoperability and information exchange (required by the HITECH Act’s Meaningful Use Stage 2), and how can they be addressed? What measures can be taken to overcome the security and privacy risks posed by mobile devices and cloud services?

Chicago Booth invites you to San Francisco for a discussion with Chicago Booth alumni and industry leaders, who will share their expertise and perspective on the current conditions as well as their views on the future outlook for the health care industry.